Liver-specific expression of transcriptionally active SREBP-1c is associated with fatty liver and increased visceral fat mass
Jebeile H, Danielsen YS, Sumithran P, et al
In another study on 59 nave patients with T2DM, alogliptin (12.5 or 25 mg/d for 3 months) showed improved -cell functioning, insulin resistance, decreased total cholesterol, and atherogenic index [59]
This built on earlier observational work
Oncogene 32 , 50785088 (2013)
Liya Kerem There have been isolated reports suggesting a link between GLP-1 receptor agonist treatment and suicidal behavior, yet no comprehensive studies have been conducted, particularly in adolescents, Liya Kerem, MD, MSc, pediatric endocrinologist at Hadassah Hebrew University Medical Center in Jerusalem, Israel, told Healio